» Articles » PMID: 37241027

Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study

Abstract

Accurately identifying metastatic disease is critical to directing the appropriate treatment in pancreatic cancer. Mucin 5AC is overexpressed in pancreatic cancer but absent in normal pancreas tissue. The present proof-of-concept study demonstrates the efficacy of an anti-mucin 5AC antibody conjugated to an IR800 dye (MUC5AC-IR800) to preferentially label a liver metastasis of pancreatic cancer () in a unique patient-derived orthotopic xenograft (PDOX) model. In orthotopic models, the mean tumor to background ratio was 1.787 (SD ± 0.336), and immunohistochemistry confirmed the expression of MUC5AC within tumor cells. MUC5AC-IR800 provides distinct visualization of pancreatic cancer liver metastasis in a PDOX mouse model, demonstrating its potential utility in staging laparoscopy and fluorescence-guided surgery.

References
1.
Kim G, Bae H, Park H, Kuan S, Crawley S, Ho J . Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology. 2002; 123(4):1052-60. DOI: 10.1053/gast.2002.36018. View

2.
Su B, Bai D, Yu J, Zhang C, Jin S, Zhou B . Can Patients with Pancreatic Cancer and Liver Metastases Obtain Survival Benefit from Surgery? A Population-Based Study. J Cancer. 2021; 12(2):539-552. PMC: 7739005. DOI: 10.7150/jca.51218. View

3.
Maawy A, Hiroshima Y, Zhang Y, Luiken G, Hoffman R, Bouvet M . Polyethylene glycol (PEG) linked to near infrared (NIR) dyes conjugated to chimeric anti-carcinoembryonic antigen (CEA) antibody enhances imaging of liver metastases in a nude-mouse model of human colon cancer. PLoS One. 2014; 9(5):e97965. PMC: 4032229. DOI: 10.1371/journal.pone.0097965. View

4.
Yamamura K, Yamashita Y, Yamao T, Kuroda D, Eto T, Kitano Y . Efficacy of Staging Laparoscopy for Pancreatic Cancer. Anticancer Res. 2020; 40(2):1023-1027. DOI: 10.21873/anticanres.14037. View

5.
Turner M, Amirfakhri S, Nishino H, Lwin T, Savides T, Reid T . A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules. In Vivo. 2021; 35(4):1959-1963. PMC: 8286470. DOI: 10.21873/invivo.12463. View